Aflibercept
2 results
Applied filters
Preparing to use aflibercept 2mg biosimilar
10 December 2025Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice.
The licence and supporting evidence for aflibercept biosimilars
28 November 2025Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.